Abstract

The diorganodiselenides (pzCH2CH2)2Se2 (1) and (PhtzCH2)2Se2 (2) were prepared by reacting Na2Se2 with 1‐(2‐bromoethyl)‐1H‐pyrazole and 4‐(chloromethyl)‐2‐phenylthiazole, respectively, while the reactions between 1‐(2‐bromoethyl)‐1H‐pyrazole or 4‐(chloromethyl)‐2‐phenylthiazole and the lithium organoselenolates [2‐(Et2NCH2)C6H4]SeLi and [2‐{O(CH2CH2)2NCH2}C6H4]SeLi in a 1:1 molar ratio resulted in the heteroleptic diorganoselenium(II) compounds [2‐(Et2NCH2)C6H4](R)Se (R = pzCH2CH2 (3) or PhtzCH2 (5)) and [2‐{O(CH2CH2)2NCH2}C6H4](R)Se (R = pzCH2CH2 (4) or PhtzCH2 (6)). The diorganotin(IV) bis(organoselenolato) derivatives of type R2Sn(SeCH2CH2pz)2 (R = 2‐(Me2NCH2)C6H4 (7) or Me (8)) were obtained by reacting (pzCH2CH2)SeNa with the appropriate diorganotin(IV)dichloride in a 2:1 molar ratio. All compounds were investigated using NMR spectroscopy (1H, 13C, 77Se, 119Sn as appropriate) and ESI+ mass spectrometry. The molecular structures of 2 and 6 were determined using single‐crystal X‐ray diffraction. The formation of a 10–Se–3 hypercoordinated species was evidenced for 6 in the solid state, as a consequence of the C,N coordination behaviour of the 2‐{O(CH2CH2)2NCH2}C6H4 group. Compounds 1, 7 and 8 were investigated for their antiproliferative activity towards the mouse colon carcinoma C26 cell line with the preliminary results showing a better activity than 5‐fluorouracil.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call